Guidelines and standards of care are helpful for many, but some populations require a more individualized approach to diabetes care. Experts, including Rodolfo J. Galindo, MD, shared the tools they’ve made available to patients who may need alternative ways to monitor and self-manage their diabetes.
Data continue to provide strong evidence favoring metabolic surgery to other treatment options for type 2 diabetes remission. Principal Investigator John Kirwan, MSc, PhD, will present ARMMS-T2D study results comparing surgery versus medical and lifestyle intervention in patients with the disease, as well as long-term effects post-surgery.
Experts in diabetes and eye health will discuss how the therapies used in the treatment of diabetes relate to the development and progression of diabetic retinopathy. Risa Wolf, MD, will share data that suggests GLP-1 receptor agonists can worsen diabetic retinopathy.